Craig Lichtenstein

Chief Operating Officer

Craig Lichtenstein is the Chief Operating Officer at EpiBiologics. Craig has over 20 years of experience leading teams in operations and supply chain across several biotechnology companies. Prior to EpiBiologics, Craig started and led the manufacturing as well as supply chain functions at Sana Biotechnology. He was previously the Vice President and Head of Technical Operations at Achaogen. Before joining Achaogen, Craig spent over 13 years at Genentech in several different leadership roles, most recently as a Technical Product Leader, ensuring reliable supply and product health across three programs. Prior to that, Craig was the Director of Pilot Plant Operations, responsible for leading all five of Genentech’s non-GMP pilot plants, and before that he worked as part of the Drug Product organization as Manager of Drug Product Filling Manufacturing for Genentech’s three commercial fill lines. Prior to Genentech, Craig spent two years in investment banking at SG Cowen followed by two years in venture capital at Pequot Capital. Craig obtained his MBA from Harvard Business School, a BA in Economics from Brown University and an AIM Certificate in Product Creation and Innovative Manufacturing from Stanford University.